This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences, Cas. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010-2012
Title: Innovations of Jie Qiu in Liver Regeneration
Introduction
Jie Qiu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in liver regeneration. With a total of 2 patents, his work focuses on innovative solutions for liver injury and related conditions.
Latest Patents
One of Jie Qiu's latest patents is titled "Human liver regeneration associated protein and the use thereof." This invention introduces a novel human liver regeneration associated protein known as hLRTM4, along with the polynucleotide that encodes this protein. The hLRTM4 protein has potential applications in treating liver injuries. Additionally, its antagonists, such as antisense nucleic acids and antibodies, can be utilized in the treatment of hepatocellular carcinoma. The invention also encompasses corresponding pharmaceutical compositions that can aid in these treatments.
Career Highlights
Jie Qiu has worked with esteemed institutions such as the Chinese Academy of Sciences and the Shanghai Institutes for Biological Sciences. His experience in these organizations has contributed to his expertise in biological sciences and innovation.
Collaborations
Some of Jie Qiu's notable coworkers include Mujun Zhao and Zhanwu Liu. Their collaborative efforts have likely enhanced the research and development of innovative solutions in the field of liver regeneration.
Conclusion
Jie Qiu's contributions to liver regeneration through his innovative patents highlight the importance of research in biotechnology. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile